Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study

Author:

Deodhar Atul1ORCID,Blanco Ricardo2,Dokoupilová Eva3,Hall Stephen4,Kameda Hideto5ORCID,Kivitz Alan J.6,Poddubnyy Denis7ORCID,Sande Marleen8,Wiksten Anna S.9,Porter Brian O.10,Richards Hanno B.9,Haemmerle Sibylle9,Braun Jürgen11

Affiliation:

1. Oregon Health & Science University Portland

2. Hospital University Marqués de Valdecilla IDIVAL Santander Spain

3. Medical Plus, s.r.o., Uherské Hradiště, Czech Republic University of Veterinary and Pharmaceutical Sciences Brno Czech Republic

4. Monash University Melbourne Victoria Australia

5. Toho University Tokyo Japan

6. Altoona Center for Clinical Research Duncansville Pennsylvania

7. Charité Universitätsmedizin Berlin Germany

8. Amsterdam UMC University of Amsterdam Amsterdam Rheumatology and Immunology Center Amsterdam The Netherlands

9. Novartis Pharma AG Basel Switzerland

10. Novartis East Hanover New Jersey

11. Rheumazentrum Ruhrgebiet, Herne, Germany, and Ruhr‐University Bochum Bochum Germany

Funder

Novartis

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3